tiprankstipranks
Trending News
More News >
Sigyn Therapeutics (SIGY)
OTHER OTC:SIGY
US Market

Sigyn Therapeutics (SIGY) Ratios

Compare
12 Followers

Sigyn Therapeutics Ratios

SIGY's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, SIGY's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.02 <0.01 0.03 0.03 0.54
Quick Ratio
0.02 <0.01 0.02 <0.01 0.47
Cash Ratio
0.02 <0.01 <0.01 <0.01 0.46
Solvency Ratio
-0.53 -0.54 -1.11 -1.66 -3.47
Operating Cash Flow Ratio
-0.23 -0.19 -0.38 -0.89 -2.42
Short-Term Operating Cash Flow Coverage
-1.25 -0.42 -0.63 -1.12 -2.56
Net Current Asset Value
$ -5.97M$ -4.65M$ -3.62M$ -2.17M$ -581.81K
Leverage Ratios
Debt-to-Assets Ratio
20.76 10.26 7.45 5.64 1.38
Debt-to-Equity Ratio
-0.48 -0.49 -0.70 -0.99 -3.70
Debt-to-Capital Ratio
-0.91 -0.97 -2.36 -72.32 1.37
Long-Term Debt-to-Capital Ratio
-0.54 0.00 0.00 0.00 0.00
Financial Leverage Ratio
-0.02 -0.05 -0.09 -0.17 -2.68
Debt Service Coverage Ratio
-2.03 -0.86 -0.58 -0.94 -2.31
Interest Coverage Ratio
-8.04 -2.93 -1.20 -3.32 -5.03
Debt to Market Cap
44.95 0.49 17.02 10.31 0.04
Interest Debt Per Share
1.90 2.29 4.04 2.70 0.04
Net Debt to EBITDA
-1.36 -0.87 -0.98 -0.87 -0.25
Profitability Margins
Gross Profit Margin
26.39%0.00%0.00%0.00%0.00%
EBIT Margin
-34747.94%0.00%0.00%0.00%0.00%
EBITDA Margin
-34700.73%0.00%0.00%0.00%0.00%
Operating Profit Margin
-32561.66%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-55785.80%0.00%0.00%0.00%0.00%
Net Profit Margin
-55785.80%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-55785.80%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%126.69%113.28%
EBT Per EBIT
171.32%132.59%168.86%136.44%149.62%
Return on Assets (ROA)
-2375.93%-1562.90%-1288.33%-1115.10%-479.22%
Return on Equity (ROE)
62.07%74.93%121.49%195.03%1286.43%
Return on Capital Employed (ROCE)
48.78%57.24%74.72%125.15%8381.89%
Return on Invested Capital (ROIC)
60.59%111.21%241.96%8271.76%-280.70%
Return on Tangible Assets
-2375.93%-1562.90%-1288.33%-1122.18%-483.10%
Earnings Yield
-5144.69%-79.58%-3193.02%-2337.78%-18.70%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
<0.01 <0.01 0.02 0.03 0.01
Inventory Turnover
0.00 0.00 0.18 0.21 0.01
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.04 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
>-0.01 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-66.44K -39.58K -16.97K -9.69K 7.03K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 2.06K 1.75K 34.05K
Days of Payables Outstanding
66.44K 39.58K 19.03K 11.44K 27.01K
Operating Cycle
0.00 0.00 2.06K 1.75K 34.05K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.58 -0.65 -1.26 -1.96 -0.05
Free Cash Flow Per Share
-0.58 -0.65 -1.26 -1.96 -0.05
CapEx Per Share
<0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
-234.11K 0.00 0.00 -2.13K -60.63
Capital Expenditure Coverage Ratio
-234.11K 0.00 0.00 -2.13K -60.63
Operating Cash Flow Coverage Ratio
-0.33 -0.40 -0.58 -0.97 -1.81
Operating Cash Flow to Sales Ratio
-162.18 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-1495.65%-20.79%-1065.29%-1153.23%-9.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.02 -1.26 -0.03 -0.04 -5.35
Price-to-Sales (P/S) Ratio
10.84 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
-0.01 -0.94 -0.04 -0.08 -68.78
Price-to-Free Cash Flow (P/FCF) Ratio
-0.07 -4.81 -0.09 -0.09 -10.09
Price-to-Operating Cash Flow Ratio
-0.07 -4.81 -0.09 -0.09 -10.26
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.04 <0.01 >-0.01 0.09
Price-to-Fair Value
-0.01 -0.94 -0.04 -0.08 -68.78
Enterprise Value Multiple
-1.39 -2.53 -1.03 -0.95 -7.46
Enterprise Value
2.79M 6.38M 2.52M 2.03M 18.84M
EV to EBITDA
-1.39 -2.53 -1.03 -0.95 -7.46
EV to Sales
483.41 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-2.98 -7.31 -1.82 -1.11 -10.45
EV to Operating Cash Flow
-2.98 -7.31 -1.82 -1.11 -10.62
Tangible Book Value Per Share
-3.69 -3.35 -3.10 -2.04 >-0.01
Shareholders’ Equity Per Share
-3.69 -3.35 -3.10 -2.04 >-0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 0.00 0.00 0.00 0.00
Net Income Per Share
-2.01 -2.51 -3.77 -3.97 -0.09
Tax Burden
1.00 1.00 1.00 1.27 1.13
Interest Burden
1.61 1.00 1.69 1.36 1.18
Research & Development to Revenue
24.26 0.00 0.00 0.00 0.00
SG&A to Revenue
283.88 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
32.47 0.00 0.00 0.00 0.00
Income Quality
0.29 0.26 0.33 0.62 0.59
Currency in USD